Autoantibody Epitope Spreading in the Pre-Clinical Phase Predicts Progression to Rheumatoid Arthritis-Reference-Cited by-同舟云学术

Autoantibody Epitope Spreading in the Pre-Clinical Phase Predicts Progression to Rheumatoid Arthritis

Published:2012-05-25 Issue:5 Volume:7 Page:e35296
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Sokolove Jeremy,Bromberg Reuven,Deane Kevin D.,Lahey Lauren J.,Derber Lezlie A.,Chandra Piyanka E.,Edison Jess D.,Gilliland William R.,Tibshirani Robert J.,Norris Jill M.,Holers V. Michael,Robinson William H.

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference54 articles.

1. Work disability in early rheumatoid arthritis.;D Doeglas;Ann Rheum Dis,1995

2. Treating rheumatoid arthritis early: a window of opportunity?;JR O'Dell;Arthritis Rheum,2002

3. Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors.;MM Nielen;Arthritis Rheum,2004

4. Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis.;S Rantapaa-Dahlqvist;Arthritis Rheum,2003

5. Duration of preclinical rheumatoid arthritis-related autoantibody positivity increases in subjects with older age at time of disease diagnosis.;DS Majka;Ann Rheum Dis,2008

Cited by 434 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Peptidylarginine deiminase (PAD): A promising target for chronic diseases treatment;International Journal of Biological Macromolecules;2024-10

2. Distinct mucosal endotypes as initiators and drivers of rheumatoid arthritis;Nature Reviews Rheumatology;2024-09-09

3. The fate of immune complexes in membranous nephropathy;Frontiers in Immunology;2024-08-08

4. Higher levels of markers for early atherosclerosis in anti-citrullinated protein antibodies positive individuals at risk for RA, a cross sectional study;Rheumatology International;2024-07-16

5. Prevention of Rheumatoid Arthritis in At-Risk Individuals: Current Status and Future Prospects;Drugs;2024-07-02